 |
|
Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy
Elena I. Fomchenko, James C. Bayley, Christopher Alvarez-Breckenridge, Laurence D. Rhines, Claudio E. Tatsui
Neurospine. 2022;19(4):978-993. Published online 2022 Dec 31 DOI: https://doi.org/10.14245/ns.2244290.145
|
|
Citations to this article as recorded by
 The Impact of Adjunct Medical Therapy on Survival after Spine Metastasis: A Systematic Review and Pooled Data Analysis
Lilly Groszman, Jonathan A. Hubermann, Paul Kooner, Nawaf Alamiri, Anthony Bozzo, Ahmed Aoude
Cancers.2024; 16(7): 1425. CrossRef Spinal Metastases from Colorectal Cancer at Mass General Brigham: A Twenty-Year Case Series With Literature Review
Alexander G. Yearley, Jack J. McNulty, Eric J. Chalif, Joshua I. Chalif, Suk Joon Lee, Neil V. Klinger, Hasan A. Zaidi
World Neurosurgery.2023; 176: e246. CrossRef The Role and Clinical Outcomes of Endoscopic Spine Surgery of Treating Spinal Metastases; Outcomes of 29 Cases From 8 Countries
Siravich Suvithayasiri, Young-Jin Kim, Yanting Liu, Warayos Trathitephun, Akarawit Asawasaksaku, Javier Quillo-Olvera, Vit Kotheeranurak, Haroldo Chagas, Cristian Correa Valencia, Marcus Vinicius Serra, Facundo Van Isseldyk, Lung-Hsing Lee, Chien-Min Chen
Neurospine.2023; 20(2): 608. CrossRef Advances in the Treatment of Spinal Metastasis: Commentary on “Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy”
Stephen Bergin, Khoi D. Than
Neurospine.2022; 19(4): 994. CrossRef
|